Motus GI Holdings Net Income 2016-2023 | MOTS
Motus GI Holdings net income from 2016 to 2023. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
| Motus GI Holdings Annual Net Income (Millions of US $) |
|
|---|---|
| 2022 | $-19 |
| 2021 | $-25 |
| 2020 | $-19 |
| 2019 | $-23 |
| 2018 | $-22 |
| 2017 | $-13 |
| 2016 | $-8 |
| 2015 | $-6 |
| Motus GI Holdings Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2023-09-30 | $-3 |
| 2023-06-30 | $-3 |
| 2023-03-31 | $-4 |
| 2022-12-31 | $-4 |
| 2022-09-30 | $-5 |
| 2022-06-30 | $-5 |
| 2022-03-31 | $-5 |
| 2021-12-31 | $-5 |
| 2021-09-30 | $-5 |
| 2021-06-30 | $-5 |
| 2021-03-31 | $-11 |
| 2020-12-31 | $-4 |
| 2020-09-30 | $-4 |
| 2020-06-30 | $-4 |
| 2020-03-31 | $-7 |
| 2019-12-31 | $-6 |
| 2019-09-30 | $-5 |
| 2019-06-30 | $-6 |
| 2019-03-31 | $-6 |
| 2018-12-31 | $-6 |
| 2018-09-30 | $-5 |
| 2018-06-30 | $-4 |
| 2018-03-31 | $-7 |
| 2017-12-31 | $-4 |
| 2017-09-30 | $-3 |
| 2017-06-30 | $-3 |
| 2017-03-31 | $-3 |
| 2016-12-31 | |
| 2016-09-30 | $-2 |
| 2015-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.000B | $0.000B |
| Motus GI Holdings, Inc. is a medical technology company. It focuses on the development and commercialization of the Pure-Vu(R) System to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon. The company also operates through subsidiaries in the U.S. and Israel. Motus GI Holdings, Inc. is based in FL, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $39.189B | 21.80 |
| Inspire Medical Systems (INSP) | United States | $6.715B | 0.00 |
| 10x Genomics (TXG) | United States | $3.670B | 0.00 |
| Axonics (AXNX) | United States | $3.435B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.419B | 0.00 |
| Enovis (ENOV) | United States | $3.098B | 23.54 |
| Azenta (AZTA) | United States | $2.910B | 237.18 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.818B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $2.719B | 0.00 |
| Privia Health (PRVA) | United States | $2.099B | 93.11 |
| Schrodinger (SDGR) | United States | $1.790B | 0.00 |
| Phreesia (PHR) | United States | $1.297B | 0.00 |
| Omnicell (OMCL) | United States | $1.224B | 29.94 |
| Definitive Healthcare (DH) | United States | $0.861B | 0.00 |
| Standard BioTools (LAB) | United States | $0.786B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.620B | 0.00 |
| Talkspace (TALK) | United States | $0.512B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.325B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.324B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.310B | 0.00 |
| Pulmonx (LUNG) | United States | $0.286B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.187B | 0.00 |
| Augmedix (AUGX) | United States | $0.168B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.149B | 0.00 |
| American Well (AMWL) | United States | $0.149B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.129B | 0.00 |
| TruBridge (TBRG) | United States | $0.122B | 5.22 |
| Outset Medical (OM) | United States | $0.108B | 0.00 |
| 111 (YI) | China | $0.084B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.076B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.074B | 0.00 |
| Zepp Health (ZEPP) | China | $0.052B | 0.00 |
| HeartBeam (BEAT) | United States | $0.047B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.045B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.034B | 0.00 |
| Movano (MOVE) | United States | $0.026B | 0.00 |
| Cue Health (HLTH) | United States | $0.023B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.019B | 0.00 |
| ETAO (ETAO) | United States | $0.019B | 0.00 |
| CareCloud (CCLD) | United States | $0.019B | 0.00 |
| Akili (AKLI) | United States | $0.018B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.017B | 0.00 |
| Centogene (CNTG) | Germany | $0.013B | 0.00 |
| Biotricity (BTCY) | United States | $0.011B | 0.00 |
| Transgenomic (PRPO) | United States | $0.010B | 0.00 |
| Syra Health (SYRA) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |